Zhitong Finance App News, Lu Kang Pharmaceutical (600789.SH) issued an announcement. Recently, the company received the “Notice of Approval of the Application for the Marketing of Chemical Ingredients” issued by the State Drug Administration regarding briprazole, and the drug approved the marketing application. Briprazole is a second-generation atypical antipsychotic. Because it balances the dopamine and serotonin systems, it can balance efficacy and safety. It is the only oral antipsychotic in the world where the risk of all side effects is not significantly different from placebo.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.